GeoVax Labs, Inc.
GOVX
$0.9213
-$0.0887-8.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 14.44% | 22.40% | 56.04% | 110.39% | 127.11% |
| Gross Profit | 4.64% | -5.47% | -53.90% | -110.39% | -129.16% |
| SG&A Expenses | -10.58% | -15.21% | -2.21% | 14.63% | 20.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.81% | 12.88% | 39.04% | 78.66% | 89.53% |
| Operating Income | 5.98% | -0.23% | -37.52% | -78.66% | -90.63% |
| Income Before Tax | 3.75% | -2.37% | -39.33% | -77.71% | -85.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.75% | -2.37% | -39.33% | -77.71% | -85.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.75% | -2.37% | -39.33% | -77.71% | -85.20% |
| EBIT | 5.98% | -0.23% | -37.52% | -78.66% | -90.63% |
| EBITDA | 6.07% | -0.11% | -37.56% | -78.87% | -90.87% |
| EPS Basic | 57.55% | 33.76% | -11.70% | -40.96% | -9.89% |
| Normalized Basic EPS | 57.55% | 33.76% | -11.70% | -40.96% | -9.89% |
| EPS Diluted | 57.55% | 33.76% | -11.70% | -40.96% | -9.89% |
| Normalized Diluted EPS | 57.55% | 33.76% | -11.70% | -40.96% | -9.89% |
| Average Basic Shares Outstanding | 196.46% | 94.02% | 30.27% | 29.50% | 52.06% |
| Average Diluted Shares Outstanding | 196.46% | 94.02% | 30.27% | 29.50% | 52.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |